Edwards Lifesciences United States — Total other segment items increased by 33.3% to $800.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.3%, from $600.00K to $800.00K. Over 3 years (FY 2022 to FY 2025), United States — Total other segment items shows a downward trend with a -19.5% CAGR.
Large fluctuations often indicate non-recurring events or one-time charges that impact the segment's profitability independently of core operations.
This metric aggregates miscellaneous income or expense items that are specific to the United States segment but fall out...
Similar to 'Other Operating Income/Expense' found in segment reporting for diversified healthcare conglomerates.
ew_segment_united_states_total_other_segment_items| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20M | $1.20M | $1.20M | $1.20M | $525.00K | $525.00K | $525.00K | $525.00K | $700.00K | $700.00K | $600.00K | $400.00K | $600.00K | $600.00K | $700.00K | $600.00K | $800.00K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -56.3% | +0.0% | +0.0% | +0.0% | +33.3% | +0.0% | -14.3% | -33.3% | +50.0% | +0.0% | +16.7% | -14.3% | +33.3% |
| YoY Change | — | — | — | — | -56.3% | -56.3% | -56.3% | -56.3% | +33.3% | +33.3% | +14.3% | -23.8% | -14.3% | -14.3% | +16.7% | +50.0% | +33.3% |